SCHEMBL5762906

SCHEMBL5762906

C[C@H](N[C@H]1CCC[C@H](c2ccccc2)NC1=O)C(N)=O

nearest known ligand 0.49

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 3/20 0.49
SCN3A Q9NY46 2/20 0.38
F2 P00734 5/20 0.35
MASP2 O00187 3/20 0.35
USP2 O75604 1/20 0.34
ALOX15 P16050 1/20 0.34
KCNH2 Q12809 2/20 0.34
RECQL P46063 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34
XIAP P98170 1/20 0.33
BIRC3 Q13489 1/20 0.33
BIRC2 Q13490 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5762190 1.00 KDM1A (0.49) KDM1ASCN3AF2MASP2USP2
SCHEMBL5761997 0.83 KDM1A (0.52) KDM1AF2MASP2KCNH2HRH3
SCHEMBL5764222 0.83 KDM1A (0.52) KDM1AF2MASP2KCNH2HRH3
SCHEMBL5764210 0.83 KDM1A (0.52) KDM1AF2MASP2KCNH2HRH3
SCHEMBL5764621 0.81 KDM1A (0.50) KDM1ASCN3AF2MASP2KCNH2
SCHEMBL5763990 0.81 KDM1A (0.50) KDM1ASCN3AF2MASP2KCNH2
SCHEMBL5762197 0.81 XIAP (0.47) XIAPBIRC3BIRC2
SCHEMBL5762909 0.81 XIAP (0.47) XIAPBIRC3BIRC2
SCHEMBL5761133 0.80 KDM1A (0.54) KDM1ASCN3AKCNH2HRH3
SCHEMBL5762404 0.80 KDM1A (0.54) KDM1ASCN3AKCNH2HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1636196-A1 NOVEL LACTAMS AND USES THEREOF AstraZeneca AB (SE) 2006-03-22 EP claimed
WO-2004080983-A1 NOVEL LACTAMS AND USES THEREOF ASTRAZENECA AB (SE) 2004-09-23 WO claimed
EP-1636196-A1 NOVEL LACTAMS AND USES THEREOF AstraZeneca AB (SE) 2006-03-22 EP disclosed
WO-2004080983-A1 NOVEL LACTAMS AND USES THEREOF ASTRAZENECA AB (SE) 2004-09-23 WO disclosed